DRIO Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 8.25
EPS (TTM)$-10.120.0% YoY
Profit margin-186.6%HEALTHCARE
Market cap$53.3MMicro cap
Wall Street coverage
$18.50median target· current $32.00 (-42.2%)5 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 8.25
- PEG ratio
- 0.00
- P/B
- 0.79
- P/S (TTM)
- 2.38
- EV/EBITDA
- -0.59
Profitability & growth
- ROE (TTM)
- -59.6%
- Operating margin
- -163.7%
- Revenue growth YoY
- -31.2%
- Dividend yield
- —
- Beta
- 1.28
Last earnings
Mar 19, 2026 · Estimate $-1.59 · Reported $-0.77
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About DarioHealth Corp
Company profileDarioHealth Corp. The company is headquartered in New York, New York.
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 322 W. 57TH STREET, NEW YORK, NY
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Market cap$53.3M
Shares outstanding$7.3M
52W high$17.74
52W low$5.93
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent